Continuous adenosine A2A receptor antagonism after focal cerebral ischemia in spontaneously hypertensive rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 387, Issue 2, 2014, Pages 165-173

  Fronz, Ulrike ^a,b,c   Deten, Alexander ^a,c   Baumann, Frank ^b   Kranz, Alexander ^a,c   Weidlich, Sarah ^b,c   Härtig, Wolfgang ^b   Nieber, Karen ^b   Boltze, Johannes ^a,c   Wagner, Daniel Christoph ^a,c  

^a Translational Centre for Regenerative Medicine   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

8 CSC; Adenosine A2A receptor; Brain ischemia; SHR rat; Stroke

Indexed keywords

8 (3 CHLOROSTYRYL)CAFFEINE; 8-(3-CHLOROSTYRYL)CAFFEINE; ADENOSINE A2 RECEPTOR ANTAGONIST; CAFFEINE; DRUG DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; DRUG EFFECT; MALE; METABOLISM; PATHOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; BRAIN; BRAIN ISCHEMIA; CAFFEINE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; RATS, INBRED SHR;

EID: 84895071951     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-013-0931-7     Document Type: Article

References (33)

1. Bluhmki E, Chamorro A, Davalos A, Machnig T, Sauce C, Wahlgren N, Wardlaw J, Hacke W (2009) Stroke treatment with alteplase given 3.0-4.545 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol 8:1095-1102
2. Brambilla R, Cottini L, Fumagalli M, Ceruti S, Abbracchio MP (2003) Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 43:190-194
3. Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, Moskowitz MA, Fink JS, Schwarzschild MA (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 19:9192-9200
4. Cronstein BN (1994) Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13
5. Cunha RA (2005) Neuroprotection by adenosine in the brain: from A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal 1:111-134
6. Denlinger CL, Stryker KK, Slusher LB, Vesell ES (1987) Studies on theophylline metabolism: autoinduction and inhibition by antipyrine. Clin Pharmacol Ther 41:522-530
7. Derkenne S, Curran CP, Shertzer HG, Dalton TP, Dragin N, Nebert DW (2005) Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1-1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice. Pharmacogenet Genomics 15:503-511
8. Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hardemark HG, Rodichok L, Saint I, Investigators II (2008) NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke 39:1751-1758
9. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391-397
10. Gao Y, Phillis JW (1994) CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci 55:PL61-PL65
11. Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, Bachmann A, Fisher M, Kaps M, Bachmann G (2004) Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 35:566-571
12. Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87:779-789
13. Jones PA, Smith RA, Stone TW (1998) Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists. Neuroscience 85:229-237
14. Kot M, Daniel WA (2008) Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat. Pharmacol Rep 60:789-797
15. Kranz A, Wagner DC, Kamprad M, Scholz M, Schmidt UR, Nitzsche F, Aberman Z, Emmrich F, Riegelsberger UM, Boltze J (2010) Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Res 1315:128-136
16. Lo EH (2009) T time in the brain. Nat Med 15:844-846
17. Mathot RA, Gubbens-Stibbe JM, Soudijn W, Jacobson KA, Ijzerman AP, Danhof M (1995) Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine. J Pharmacol Exp Ther 275:245-253
18. Matsumoto K, Graf R, Rosner G, Shimada N, Heiss WD (1992) Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia. Brain Res 579:309-314
19. Melani A, Cipriani S, Vannucchi MG, Nosi D, Donati C, Bruni P, Giovannini MG, Pedata F (2009) Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia. Brain 132:1480-1495
20. Melani A, Pantoni L, Bordoni F, Gianfriddo M, Bianchi L, Vannucchi MG, Bertorelli R, Monopoli A, Pedata F (2003) The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Res 959:243-250
21. Monopoli A, Lozza G, Forlani A, Mattavelli A, Ongini E (1998) Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. Neuroreport 9:3955-3959
22. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59:467-477
23. O'Regan MH, Simpson RE, Perkins LM, Phillis JW (1992) The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci Lett 138:169-172
24. Petroni A, Papini N, Blasevich M, Galli C (2002) Blockade of A(2A) adenosine receptors leads to c-fos inhibition in a rat model of brain ischemia. Pharmacol Res 45:125-128
25. Phillis JW (1989) Adenosine in the control of the cerebral circulation. Cerebrovasc Brain Metab Rev 1:26-54
26. Phillis JW (1995) The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res 705:79-84
27. Sandoli D, Chiu PJ, Chintala M, Dionisotti S, Ongini E (1994) In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit. Eur J Pharmacol 259:43-49
28. Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123-130
29. Shichita T, Ago T, Kamouchi M, Kitazono T, Yoshimura A, Ooboshi H (2012) Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J Neurochem 123(Suppl 2):29-38
30. Tamura A, Graham DI, McCulloch J, Teasdale GM (1981) Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53-60
31. Von Lubitz DK, Lin RC, Jacobson KA (1995) Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist. Eur J Pharmacol 287:295-302
32. Wang Q, Tang XN, Yenari MA (2007) The inflammatory response in stroke. J Neuroimmunol 184:53-68
33. Yu L, Huang Z, Mariani J, Wang Y, Moskowitz M, Chen JF (2004) Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat Med 10:1081-1087